Disregulations of PURPL and MiR-338-3p Could Serve As Prognosis Biomarkers for Epithelial Ovarian Cancer
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 12 (18) , 5674-5680
Abstract
Objective: The present study aimed to explore the expressions of long noncoding RNA (lncRNA) p53 upregulated regulator of p53 levels (PURPL) in different ovarian tissues, and to evaluate the significance of disregulations of PURPL and microRNA-338-3p (miR-338-3p) in epithelial ovarian cancer (EOC).Keywords
This publication has 32 references indexed in Scilit:
- From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasisInternational Journal of Cancer, 2016
- DIANA-LncBase v2: indexing microRNA targets on non-coding transcriptsNucleic Acids Research, 2015
- MicroRNA-338-3p functions as tumor suppressor in breast cancer by targeting SOX4International Journal of Oncology, 2015
- Long noncoding RNAs: a potential novel class of cancer biomarkersFrontiers in Genetics, 2015
- miR-338-3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2International Journal of Oncology, 2015
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq dataNucleic Acids Research, 2013
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortalScience Signaling, 2013
- RETRACTED AND REPLACED: microRNA involvement in human cancerCarcinogenesis, 2012
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patientsBreast Cancer Research and Treatment, 2009
- Small silencing RNAs: an expanding universeNature Reviews Genetics, 2009